Form DEL AM - Delaying amendment
21 9월 2023 - 11:53PM
Edgar (US Regulatory)
BIOXYTRAN,
INC.
75
2nd Ave., Ste 605
Needham,
Massachusetts 02494
September
21, 2023
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporate Finance
100
F Street N.W.
Washington,
D.C. 20549
Re: |
Bioxytran,
Inc. –
Registration
Statement on Form S-1, Registration No. 333-274576 Delaying Amendment. |
Ladies
and Gentlemen:
Bioxytran,
Inc. (the “Registrant”) hereby respectfully submits this corrected Delaying Amendment to the Registrant’s
Registration Statement on Form S-1 (File No. 333-274576), together with all exhibits thereto, initially filed on September 19, 2023 (the
“Registration Statement”).
The
Company hereby amends the “Delaying Amendment” language contained in Exhibit 107 to the Registration Statement to read as
follows:
“The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date
as the Commission acting pursuant to said section 8(a), may determine.”
If
you have any questions with respect to this matter, please contact Robert J. Burnett, Witherspoon Brajcich McPhee, PLLC at (509) 455-9077.
|
Sincerely,
BIOXYTRAN,
INC. |
|
|
|
/s/
Ola Soderquist |
|
Ola
Soderquist
Chief
Financial Officer |
Bioxytran (QB) (USOTC:BIXT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Bioxytran (QB) (USOTC:BIXT)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Bioxytran Inc (QB) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Bioxytran Inc (QB) News Articles